L. Matter et D. Germann, DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 ANTIBODIES BY NEW AUTOMATED MICROPARTICLE ENZYME-IMMUNOASSAY FOR HIV TYPE-1 AND TYPE-2, Journal of clinical microbiology, 33(9), 1995, pp. 2338-2341
We compared an automated microparticle double-antigen sandwich enzyme
Immunoassay (EIA) for the IMx test system recently developed by Abbott
with two established assays (the automated indirect Vidas IgG EIA and
the double-antigen sandwich EIA from Murex/Wellcome) devised for the
detection of human immunodeficiency virus type 1 (HIV-1) and HIV-2 ant
ibodies. A total of 1,078 consecutive serum samples were tested prospe
ctively with the three assays, In addition, we used retrospectively se
lected panels of serum samples with discrepant results in two differen
t screening tests and with indeterminate or positive Western immunoblo
t (WB) results, as well as five commercially available HIV-1 seroconve
rsion panels, The new assay showed excellent discriminatory characteri
stics for the separation of samples from HIV-1-positive and HIV-1-nega
tive persons according to Centers for Disease Control and Prevention W
E criteria, The sensitivities were 98.1, 92.9, and 96.1% for the new t
est and the two other assays, respectively, and the specificities were
99.7, 97.9, and 98.1%, respectively, With the seroconversion panels t
his new test was positive several days earlier than the two other assa
ys; i.e.,, seroconversion was evident at the peak of p24 antigenemia a
nd often several weeks before WE became positive by the most stringent
criteria.